Table 2.
Characteristics of participants with non–vitamin K antagonist oral anticoagulant (NOAC)–associated intracerebral hemorrhage (ICH) and vitamin K antagonist (VKA)–associated ICH
Characteristics of participants with non–vitamin K antagonist oral anticoagulant (NOAC)–associated intracerebral hemorrhage (ICH) and vitamin K antagonist (VKA)–associated ICH